帕奎莫德(ABR 25757)

CAS: 248282-01-1 货号: P655090 分子式: C21H22N2O3 分子量: 350.41 EC号: 607-446-0
有货
级别和纯度: 10mM in DMSO
别名
帕喹莫德
储存条件
-80℃储存
运输条件
特低温运输
★
规格
库存
价格
数量
1ml
P655090-1ml
期货 Stock Image
¥699.90
请输入您要添加的产品数量

概述


Paquinimod (ABR 25757) is a specific and orally active inhibitor of S100A8/S100A9 . Paquinimod rescues the pneumonia with substantial reduction of viral loads in SARS-CoV-2-infected mice

In Vivo

S100A9 is a calcium-binding protein of the S100 family. Paquinimod is an immunomodulatory compound preventing S100A9 binding to TLR-4. Prophylactic treatment with S100A9 inhibitor Paquinimod reduces pathology in experimental collagenase-induced osteoarthritis . Paquinimod is a potent inhibitor of insulitis and diabetes development in the NOD mouse. To assess the preventive efficacy of Paquinimod on diabetes development in female NOD mice, groups of mice are treated with daily doses of 0.04, 0.2, 1, and 5 mg/kg/day of Paquinimod from week 10 of age until week 20 of age. Glycosuria is analyzed on a weekly basis from 10 weeks of age until the endpoint of the experiment at 40 weeks of age. There is a clear dose-dependent reduction in diabetes development in the Paquinimod-treated mice. MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Animal administration

Mice Female NOD/MrkTac mice are exposed to increasing concentration of CO 2 and upon loss of consciousness euthanized by cervical dislocation. To investigate the effect of the Q-compound Paquinimod on development of glycosuria and insulitis, mice are treated with Paquinimod dissolved in drinking water at different concentrations corresponding to daily doses of about 0.04, 0.2, 1, and 5 mg/kg body weight/day ). The mice are treated with Paquinimod starting from either 10 or 15 weeks of age. The duration of treatment varies from 5 to 23 weeks in the different experiments performed . aladdin has not independently confirmed the accuracy of these methods. They are for reference only.

IC50& Target:S100A9

规格

别名
帕喹莫德
规格或纯度
10mM in DMSO
英文名称
Paquinimod(ABR 25757)
生化机理
Paquinimod(ABR 25757)是一种特异性口服活性 S100A8/S100A9 抑制剂。Paquinimod 可挽救 SARS-CoV-2 感染小鼠的肺炎,并显著降低病毒载量。
储存条件
-80℃储存
运输条件
特低温运输
作用类型
抑制剂
名称和识别符
EC号
607-446-0
分子类型
小分子
Isomeric SMILES
CCC1=C2C(=CC=C1)N(C(=O)C(=C2O)C(=O)N(CC)C3=CC=CC=C3)C
关联CAS
MeSH Entry Terms
ABR-215757;paquinimod
分子量
350.41

高级数据

安全和危险性(GHS)
质检证书(CoA,COO,BSE/TSE 和分析图谱)
C of A & Other Certificates(BSE/TSE, COO):
输入批号以搜索分析图谱:
溶液计算器

常见问题

本产品如何运输?
本产品采用干冰配冷袋冷冻运输。收货后请立即拆包,并按上述储存条件保存;处理干冰时请戴隔热手套并保持通风。
本产品的 CAS 号、分子式和分子量是多少?
本产品的 CAS 号为 248282-01-1,分子式为 C21H22N2O3,分子量为 350.41 g/mol。
如何获取批次专用COA?
每个订单都会随附分析证书(COA),您也可以从账户订单历史中下载。如需订购前的COA,请联系您的客户代表,或使用PDP上的"申请COA"按钮——我们将提供代表性批次的COA。
本产品应如何储存?
请于?80 °C条件下保存。需超低温保存以维持规定的有效期。